Warning: The NCBI web site requires JavaScript to function. more...
What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.
Kinyanjui SM, Bejon P, Osier FH, Bull PC, Marsh K.
Malar J. 2009 Oct 28;8:242. Review.
Related citations
Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
Høgh B.
Scand J Infect Dis Suppl. 1996;102:1-53. Review.
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection.
Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM.
Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):293-303.
Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
Lynch MM, Cernetich-Ott A, Weidanz WP, Burns JM Jr.
Clin Vaccine Immunol. 2009 Mar;16(3):293-302. Epub 2008 Dec 30.
The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens.
Riley EM.
Parasitology. 1996;112 Suppl:S39-51. Review.
A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.
Fonjungo PN, Elhassan IM, Cavanagh DR, Theander TG, Hviid L, Roper C, Arnot DE, McBride JS.
Infect Immun. 1999 Jun;67(6):2975-85.
A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.
Riley EM, Morris-Jones S, Blackman MJ, Greenwood BM, Holder AA.
Parasite Immunol. 1993 Sep;15(9):513-24.
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.
Perlmann H, Perlmann P, Berzins K, Wåhlin B, Troye-Blomberg M, Hagstedt M, Andersson I, Högh B, Petersen E, Björkman A.
Immunol Rev. 1989 Dec;112:115-32. Review.
Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children.
Riley EM, Allen SJ, Bennett S, Thomas PJ, O'Donnell A, Lindsay SW, Good MF, Greenwood BM.
Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):648-57.
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K.
Infect Immun. 2008 May;76(5):2240-8. Epub 2008 Mar 3.
Malaria vaccine.
Khurana SK, Talib VH.
Indian J Pathol Microbiol. 1996 Dec;39(5):433-41.
Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
Petritus PM, Burns JM Jr.
J Immunol. 2008 Jan 1;180(1):444-53.
Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.
Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K.
J Infect Dis. 2004 Nov 1;190(9):1527-33. Epub 2004 Sep 22.
Correlation between serum levels of antibodies to the 96-kD antigen of Plasmodium falciparum and protective immunity in Cameroon: a longitudinal study.
Nkuo-Akenji T, Deas JE, Leke RG, Ngu JL.
Am J Trop Med Hyg. 1993 Nov;49(5):566-73.
Immunity to blood stages of Plasmodium falciparum is dependent on a specific pattern of immunoglobulin subclass responses to multiple blood stage antigens.
Eisenhut M.
Med Hypotheses. 2007;69(4):804-8. Epub 2007 Mar 26.
Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi-immune African children.
Riley EM, Jakobsen PH, Allen SJ, Wheeler JG, Bennett S, Jepsen S, Greenwood BM.
Eur J Immunol. 1991 Apr;21(4):1019-25.
Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea.
Stirnadel HA, Beck HP, Alpers MP, Smith TA.
Genet Epidemiol. 1999;17(1):16-34.
Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: specificity of immunity generated in hyperimmune mice.
Mota MM, Brown KN, Do Rosário VE, Holder AA, Jarra W.
Infect Immun. 2001 Apr;69(4):2535-41.
Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
Soe S, Theisen M, Roussilhon C, Aye KS, Druilhe P.
Infect Immun. 2004 Jan;72(1):247-52.
Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines.
Mendis KN, David PH, Carter R.
Int J Parasitol. 1990 Jul;20(4):497-502. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on